A method for simultaneous study of the karyotype, morphology, and immunologic phenotype of mitotic cells in hematologic malignancies.
A major problem in the cytogenetic analysis of hematologic neoplasms has been an inability to identify the cell from which the chromosomes were obtained. We describe a procedure that allows simultaneous analysis of karyotype and cell cytology in mitotic cells. The method differs from conventional cytogenetic analysis in that after mild hypotonic treatment, the cells are cytocentrifuged onto glass slides. In mitotic cells, this procedure often results in adequate spread of the chromosomes within the intact cell membrane. The cytoplasmic structure also remains intact, so that cytologic preparations are of good quality. Morphologic and immunologic identification of mitotic cells can be done using routine hematologic stains, such as Giemsa or Sudan black B, and various antisera using immunofluorescence techniques. The chromosomes can be simultaneously analyzed either without banding on slides stained with Giemsa or with Q-banding on slides stained with immunofluorescence techniques. Identification of numerical and structural karyotype aberrations thus is possible in morphologically identified cells.
D000368:Aged; D001773:Blood Cells / Q000166:cytology*; D001854:Bone Marrow Cells; D002869:Chromosome Aberrations; D004912:Erythrocytes / Q000166:cytology; D005260:Female; D006021:Glycophorins / Q000276:immunology; D006651:Histocytochemistry; D006801:Humans; D007106:Immune Sera; D007621:Karyotyping; D007938:Leukemia / Q000235:genetics / Q000473:pathology*; D007951:Leukemia, Myeloid / Q000175:diagnosis; D008875:Middle Aged; D008938:Mitosis; D010641:Phenotype; D013194:Staining and Labeling
D006021:Glycophorins; D007106:Immune Sera